EmergingResearch compound

DNP

DO NOT USE. 2,4-dinitrophenol, with risk of fatal hyperthermia. Educational context to make the dangers known.

DNP vial

WHAT IS DNP?

Detailed overview

**WARNING: DNP use is EXTREMELY DANGEROUS, with documented fatal hyperthermia cases (Grundlingh 2011 systematic review). This entry is included for educational purposes only and DOES NOT provide usage guidance. Please do not use it, and inform others of the dangers.** 2,4-dinitrophenol (DNP) is an industrial chemical (dyes, explosives) briefly marketed as an anti-obesity drug in the 1930s in the US. It uncouples mitochondrial oxidative phosphorylation: protons from the electron transport chain bypass ATP synthase, and the released energy dissipates as heat. **ATP/heat dissipation quantitative detail**: a healthy mitochondrion produces 38 ATP per glucose molecule; on DNP this drops to ~10-15 ATP, with the missing energy uncontrollably dissipating as heat. Result: extreme BMR rise (up to +50%), but uncontrollable hyperthermia which can cause 41-43°C body temperature and death. **Bodybuilder use pattern (Petróczi 2015 PMID 26092626 inline)**: based on a pre-contest "magic bullet" myth; online bodybuilding forums still circulate 200-400 mg/day protocols that approach or exceed the lethal 4.3 mg/kg threshold (~300 mg in an adult). Most deaths involved healthy men aged 21-32. **Lethal hyperthermia onset**: 41-43°C body temperature within 6-12 h after acute dosing – sweating → tachycardia → tachypnea → confusion → seizure → organ failure. There is NO antidote (ice bath + ICU support, often too late).

Mechanism

Mitochondrial uncoupler (ATP synthesis bypass)

Half-life

~36 hours (therapeutic dose, but cumulative)

Lethal dose

Acute: 4.3 mg/kg (~300 mg in adult)

Legal status

USA: FDA withdrew 1938. EU/HU: prohibited for human use. WADA: banned.

Data console

Lab data

/lab/molecular-data.jsonLIVE
> Androgenic:Anabolic-
> AR bindingN/A
> Active half-life~36 h (cumulative)
> Detection windowN/A
> AromatizationNot applicable – industrial nitroaromatic compound (2,4-dinitrophenol mitochondrial uncoupler), NOT a steroid
> HepatotoxicitySevere – multi-organ toxic; hyperthermia (>42°C), rhabdomyolysis, acute liver failure, MOF; fatalities reported independent of dose above 600 mg (Grundlingh 2011 PMID 21739343)

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Lethal, uncontrollable hyperthermia: body temperature can rise to 41–43°C with sweating, tachycardia and tachypnoea; documented fatal cases (Grundlingh 2011).
  • Profuse sweating and severe dehydration with electrolyte disturbances that further worsen the hyperthermia.
  • Tachycardia and tachypnoea (rapid heartbeat and breathing), restlessness and palpitations driven by the surge in metabolic load.
  • Rhabdomyolysis (muscle breakdown) that can lead to acute kidney failure.
  • Acute liver and multi-organ failure (MOF); high doses (>600 mg) can be fatal regardless of tolerance (Grundlingh 2011).
  • Confusion, agitation, seizures and coma due to hyperthermic central nervous system injury.
  • Cataracts and visual impairment, plus skin rash (dermatitis) with repeated exposure; yellow staining is characteristic.
  • Cumulative toxicity: with a ~36 h half-life, fatal hyperthermia can develop even 24–48 h AFTER the last dose. There is NO antidote, only ice cooling and intensive care.

Contraindications · 7

  • Any human (medical or weight-loss) use is absolutely contraindicated: withdrawn by the FDA in 1938, banned for human use in the EU, Hungary and Poland, prohibited by WADA. There is NO safe dose.
  • Hot or humid environments, physical exertion, sport and sauna: heat production and ambient heat add up, further raising the risk of fatal hyperthermia.
  • Concurrent thyroid hormones, stimulants (caffeine, ephedrine, clenbuterol, amphetamines) and any metabolism/heat-increasing agent: additive hyperthermia and cardiac strain.
  • Cardiovascular disease (arrhythmia, coronary disease, hypertension): the tachycardia and metabolic load can cause life-threatening cardiac decompensation.
  • Impaired kidney or liver function: slow clearance increases accumulation and the risk of multi-organ failure.
  • Pregnancy and breastfeeding: the compound is severely toxic with teratogenic potential and fetal hyperthermia risk; absolutely contraindicated.
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency: the nitroaromatic compound can trigger haemolysis and methaemoglobinaemia, worsening hypoxia and outcome.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about DNP?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.